Pacemaker Implantation Rates With the Self‐Expandable Navitor Valve

Background Transcatheter aortic valve replacement using self‐expandable valves requires permanent pacemaker implantation (PPI) more often compared with balloon‐expandable systems. The Navitor prosthesis is a novel, tubular‐shaped self‐expandable valve with increasing use. Methods Thirty‐day PPI rates were compared between 148 patients treated with the Navitor system and 165 patients treated with the Evolut system. Patients with preexisting PPI, high‐risk ECG (right bundle‐branch block), and Navitor 35‐mm/Evolut 34‐mm prostheses were excluded. Multivariable logistic regression was used to adjust for baseline differences. Results Patients treated with Navitor were older (83.0 [IQR, 78–86] versus 81.0 [IQR, 76–84] years; P < 0.01) and had higher Society of Thoracic Surgeons mortality risk (5.6% [IQR, 3.0%–9.9%] versus 4.3% [IQR, 2.5%–7.0%]; P = 0.04). Overall, PPI occurred more frequently with Navitor (17.6%) than with Evolut (6.7%; P < 0.01), and this difference persisted after adjustment (adjusted odds ratio, 3.07 [95% CI, 1.10–8.40]; P = 0.03; adjusted probability, 17.7% [95% CI, 15.1%–20.2%] versus 6.7% [95% CI, 5.5%–7.9%]). In patients with small annuli (